COLD AGGLUTININS AND CARDIAC SURGEY: A CASE REPORT
DOI:
https://doi.org/10.48729/pjctvs.108Abstract
Cold agglutinins (CA) are autoantibodies whose clinical significance depends upon titer and thermal amplitude. Patients, which undergo cardio-pulmonary bypass and especially hypothermic cardioplegia myocardial protection, represent a challenge regarding operative management, as tissue temperature should be maintained above the threshold of agglutination. We report on a case in which the presence of CA was discovered during elective aortic valve replacement surgery, and managed with normothermic cardiopulmonary bypass and continuous retrograde warm blood cardioplegia administration.
Downloads
References
Kansaku R, Kuwaki K, Amano A, Inaba H, Tambara K, Yamamoto T, Sakakibara N. Aortic valve replacement to a patient with high titer of cold agglutinin. Ann Thorac Cardiovasc Surg. 2012;18(3):259-61.
Kalra A, Singh K, Sahoo M, Mahant TS. Cold agglutinin disease detected during open heart surgery. Indian J Hematol Blood Transfus. 2014 Mar;30(1):62-3.
Shah S, Gilliland H, Benson G. Agglutinins and cardiac surgery: a web based survey of cardiac anaesthetic practice; questions raised and possible solutions. Heart, Lung and Vessels. 2014; 6(3): 187-196.
Cho SH, Kim DH, Kwak YT. Normothermic cardiac surgery with warm blood cardioplegia in patient with cold agglutinins. Korean J Thorac Cardiovasc Surg. 2014 Apr;47(2):133-6.
Atkinson VP, Soeding P, Horne G, Tatoulis J. Cold agglutinins in cardiac surgery: management of myocardial protection and cardiopulmonary bypass. Ann Thorac Surg 2008; 85:310-1.
Kanemitsu S, Onoda K, Yamamoto K, Shimpo H. Simple preoperative management for cold agglutinins before cardiac surgery. J Thorac Cardiovasc Surg. 2010 Nov;140(5):e73-4.
Barbara DW, Mauermann WJ, Neal JR, Abel MD, Schaff HV, Winters JL. Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2013 Sep;146(3):668-80.
